267 related articles for article (PubMed ID: 34185066)
1. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial.
Martens P; Dupont M; Dauw J; Nijst P; Herbots L; Dendale P; Vandervoort P; Bruckers L; Tang WHW; Mullens W
Eur Heart J; 2021 Dec; 42(48):4905-4914. PubMed ID: 34185066
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy.
Martens P; Dupont M; Dauw J; Somers F; Herbots L; Timmermans P; Verwerft J; Mullens W
ESC Heart Fail; 2019 Dec; 6(6):1208-1215. PubMed ID: 31562751
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous ferric carboxymaltose on right ventricular function - insights from the IRON-CRT trial.
Martens P; Dupont M; Dauw J; Nijst P; Bertrand PB; Tang WHW; Mullens W
Eur J Heart Fail; 2022 Jun; 24(6):1106-1113. PubMed ID: 35303390
[TBL] [Abstract][Full Text] [Related]
4. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
[TBL] [Abstract][Full Text] [Related]
5. Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
Butler J; Khan MS; Friede T; Jankowska EA; Fabien V; Goehring UM; Dorigotti F; Metra M; Piña IL; Coats AJS; Rosano G; Comin-Colet J; Van Veldhuisen DJ; Filippatos GS; Anker SD; Ponikowski P
Eur J Heart Fail; 2022 May; 24(5):821-832. PubMed ID: 35279929
[TBL] [Abstract][Full Text] [Related]
6. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.
Santas E; Del Canto I; Cardells I; Miñana G; Llàcer P; Almenar L; Fácila L; Maceira AM; Sanchis J; Núñez J;
ESC Heart Fail; 2024 Apr; 11(2):1258-1262. PubMed ID: 38115745
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
van Veldhuisen DJ; Ponikowski P; van der Meer P; Metra M; Böhm M; Doletsky A; Voors AA; Macdougall IC; Anker SD; Roubert B; Zakin L; Cohen-Solal A;
Circulation; 2017 Oct; 136(15):1374-1383. PubMed ID: 28701470
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy.
Bozcali E; Polat V
Acta Cardiol Sin; 2024 Mar; 40(2):182-190. PubMed ID: 38532812
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatemia Is Common After Intravenous Ferric Carboxymaltose Infusion Among Patients With Symptomatic Heart Failure With Reduced Ejection Fraction.
Dashwood A; Vale C; Laher S; Chui F; Hay K; Wong YW
J Clin Pharmacol; 2021 Apr; 61(4):515-521. PubMed ID: 33051909
[TBL] [Abstract][Full Text] [Related]
10. Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
Anker SD; Ponikowski P; Khan MS; Friede T; Jankowska EA; Fabien V; Goehring UM; Metra M; Piña IL; Coats AJS; Rosano G; Dorigotti F; Comin-Colet J; Van Veldhuisen DJ; Filippatos GS; Butler J
Eur J Heart Fail; 2022 May; 24(5):833-842. PubMed ID: 35334136
[TBL] [Abstract][Full Text] [Related]
11. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes.
Galand V; Ghoshhajra B; Szymonifka J; Das S; Orencole M; Barré V; Martins RP; Leclercq C; Hung J; Truong QA; Singh JP
Europace; 2020 Mar; 22(3):401-411. PubMed ID: 31865389
[TBL] [Abstract][Full Text] [Related]
13. The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT Study.
Lacour P; Dang PL; Morris DA; Parwani AS; Doehner W; Schuessler F; Hohendanner F; Heinzel FR; Stroux A; Tschoepe C; Haverkamp W; Boldt LH; Pieske B; Blaschke F
ESC Heart Fail; 2020 Jun; 7(3):1072-1084. PubMed ID: 32189474
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Jankowska EA; Kirwan BA; Kosiborod M; Butler J; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Filippatos G; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Friede T; Fabien V; Dorigotti F; Pocock S; Ponikowski P
Eur Heart J; 2021 Aug; 42(31):3011-3020. PubMed ID: 34080008
[TBL] [Abstract][Full Text] [Related]
15. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
[TBL] [Abstract][Full Text] [Related]
16. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.
Del Canto I; Santas E; Cardells I; Miñana G; Palau P; Llàcer P; Fácila L; López-Vilella R; Almenar L; Bodí V; López-Lereu MP; Monmeneu JV; Sanchis J; Moratal D; Maceira AM; de la Espriella R; Chorro FJ; Bayés-Genís A; Núñez J;
J Am Heart Assoc; 2022 Apr; 11(7):e022214. PubMed ID: 35301854
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular-only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial.
Su Y; Hua W; Shen F; Zou J; Tang B; Chen K; Liang Y; He L; Zhou X; Zhang X; Lu H; Zhang S
Clin Cardiol; 2021 Sep; 44(9):1225-1232. PubMed ID: 34342026
[TBL] [Abstract][Full Text] [Related]
19. [Influence of diastolic filling pattern on the efficacy of cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy].
Wang Q; Chen K; Yu F; Su H; An C; Hu Y; Yang D; Xu J; Yan J
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):189-94. PubMed ID: 26879720
[TBL] [Abstract][Full Text] [Related]
20. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
